title: Current treatment and management of pyridoxine-dependent epilepsy.
abstract: Pyridoxine-dependent epilepsy (PDE) is a rare autosomal recessive disorder and is considered as a prototypical form of metabolic epilepsy. Characterized by recurrent seizures in the prenatal, neonatal, and/or postnatal periods that are resistant to conventional anti-epileptic drugs, PDE is responsive to pharmacological dosages of pyridoxine. Presently, however, there are no clear dose recommendations for long-term treatment. While pyridoxine supplementation is the first line of treatment and should be initiated in all confirmed PDE patients at an early age, various other treatment strategies are emerging. These include a lysine-restricted diet and arginine fortification. These will be discussed in light of current evidence, together with recommendations for best management of patients with this rare but treatable metabolic epilepsy, and future research and collaborative efforts, including the International PDE Consortium.
authors: Division of Biochemical Diseases, Department of Pediatrics, BC Children's Hospital, Rm K3-201, 4480 Oak Street, Vancouver, BC, V6H 3V4, Canada, cvankarnebeek@cw.bc.ca.
authors: Clara D M
authors: CD
authors: van Karnebeek
authors: Sravan
authors: S
authors: Jaggumantri
references: Mol Genet Metab. 2012 Nov;107(3):335-44
references: 23022070
references: J Neurochem. 1981 Jan;36(1):251-7
references: 7463050
references: J Pediatr. 1998 Jun;132(6):919-23
references: 9627579
references: Mol Genet Metab. 2012 Sep;107(1-2):72-80
references: 22520952
references: Arch Dis Child Fetal Neonatal Ed. 1999 Sep;81(2):F125-9
references: 10448181
references: Can J Neurol Sci. 1995 Feb;22(1):50-1
references: 7750075
references: Arch Dis Child. 2005 Dec;90(12):1293-6
references: 16159904
references: Dev Med Child Neurol. 2011 Dec;53(12):1150-3
references: 21707605
references: Pediatr Neurol. 2002 Mar;26(3):181-5
references: 11955923
references: Ann Neurol. 1985 Feb;17(2):117-20
references: 3977296
references: Eur J Pediatr. 1991 May;150(7):452-5
references: 1915493
references: J Child Neurol. 1996 Sep;11(5):422-4
references: 8877616
references: Dev Med Child Neurol. 1996 Nov;38(11):998-1006
references: 8913181
references: Brain. 2010 Jul;133(Pt 7):2148-59
references: 20554659
references: J Inherit Metab Dis. 2007 Feb;30(1):96-9
references: 17216302
references: Epileptic Disord. 2013 Dec;15(4):400-6
references: 24184718
references: J Inherit Metab Dis. 2011 Jun;34(3):677-94
references: 21431622
references: Brain. 2014 May;137(Pt 5):1350-60
references: 24645144
references: Lancet. 1999 Dec 11;354(9195):2082-3
references: 10636399
references: Dev Med Child Neurol. 1999 Mar;41(3):203-6
references: 10210253
references: Dev Med Child Neurol. 2003 Nov;45(11):782-5
references: 14580135
references: Ann Neurol. 2009 May;65(5):550-6
references: 19142996
references: Arch Dis Child. 2005 May;90(5):512-5
references: 15851435
references: J Inherit Metab Dis. 2010 Oct;33(5):571-81
references: 20814824
references: Eur J Paediatr Neurol. 1998;2(6):319-22
references: 10727199
references: Pediatrics. 2012 Dec;130(6):e1716-9
references: 23147983
references: J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):317-26
references: 16763894
references: Eur J Paediatr Neurol. 2014 Nov;18(6):741-6
references: 25127453
references: J Inherit Metab Dis. 2012 Nov;35(6):1031-6
references: 22403017
references: Eur J Pediatr. 2009 Jun;168(6):697-704
references: 18762976
references: Neuropediatrics. 2008 Oct;39(5):276-9
references: 19294602
references: Dev Med Child Neurol. 2007 Apr;49(4):300-5
references: 17376142
references: Chang Gung Med J. 2010 Jan-Feb;33(1):1-12
references: 20184790
references: JIMD Rep. 2014;15:1-11
references: 24748525
references: Curr Opin Neurol. 2006 Apr;19(2):148-53
references: 16538088
references: J Inherit Metab Dis. 2012 Nov;35(6):1147-52
references: 22358739
references: Dev Med Child Neurol. 2012 Sep;54(9):849-54
references: 22804844
references: J Pediatr. 1999 Jun;134(6):795-6
references: 10356240
references: Pediatrics. 1954 Feb;13(2):140-5
references: 13133562
references: Mol Genet Metab. 2011 Sep-Oct;104(1-2):48-60
references: 21704546
references: Mol Genet Metab. 2013 Nov;110(3):237-40
references: 23953072
references: Eur J Pediatr. 2010 Mar;169(3):297-303
references: 19588165
references: Arch Dis Child. 1999 Nov;81(5):431-3
references: 10519720
references: Epilepsia. 2013 Feb;54(2):239-48
references: 23350806
references: Neurology. 2014 Apr 22;82(16):1425-33
references: 24658933
references: Arch Dis Child. 1983 Jun;58(6):415-8
references: 6859931
references: Nat Med. 2006 Mar;12(3):307-9
references: 16491085
references: Brain. 2011 Jan;134(Pt 1):157-70
references: 20923787
references: Arch Dis Child Fetal Neonatal Ed. 2008 Mar;93(2):F151-2
references: 18296573
references: Pediatrics. 1992 Aug;90(2 Pt 1):221-3
references: 1641285
references: Mol Genet Metab. 2012 Mar;105(3):368-81
references: 22212131